Merck Sharp & Dohme LLC and Otsuka Pharmaceutical Co. Ltd. have patented cellular tumor antigen p53 (TP53) (Y220C mutant) activators reported to be useful for the treatment of cancer.
Merck Sharp & Dohme LLC has identified plasma kallikrein (KLKB1) Inhibitors reported to be useful for the treatment of diabetic retinopathy, retinal vein occlusion, hereditary angioedema, diabetes, ...
The positions in the table below reflect the Merck Sharp and Dohme B.V. (MSD BV Haarlem)'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each ...
German science and technology company Merck is to close its operation in Co Wicklow by the end of 2028, with the loss of 100 ...
The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of new vaccines. A team of researchers at Purdue University and Merck & Co. Inc.
Dr. Reddy’s (RDY) Laboratories and Senores Pharmaceuticals announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and therapeutically equivalent to STROMECTOL Tablets of Merck ...
HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and ...
The U.S. Supreme Court on Monday denied a petition for a writ of certiorari filed by the drug company Merck Sharp & Dohme Corp., bringing to a close a decade-long legal battle that had stalled ...
Global drug manufacturer Merck & Co. (MRK) was founded in 1891 in Rahway, New Jersey, where it is also headquartered. It operates worldwide, primarily providing pharmaceutical prescription drugs along ...
Merck Sharp & Dohme was hit with a patent infringement lawsuit on Sept. 5 in New Jersey District Court over its Capvaxive pneumococcal vaccine. The suit, brought by Sills Cummis & Gross and Skiermont ...
Article ‘Count’ and ‘Share’ for Merck Sharp and Dohme B.V. (MSD BV Haarlem) based on listed parameters only. The articles listed below published by authors from Merck Sharp and Dohme B.V. (MSD BV ...